All companies

Regulators & Public Bodies

FDA

Ecosystem Private
Headquarters
Silver Spring, MD, US
Segment
Regulators & Public Bodies
Stories held
1
Last story
1 Aug 2026

The FDA is a US federal agency within the Department of Health and Human Services that regulates the safety and labelling of food, drugs, biologics, medical devices and tobacco products. Its rules on container closures and packaging materials directly affect pharmaceutical and food packaging suppliers.

1 stories · 2026

FDA issues draft guidance overhauling pharma container closure requirements

The US FDA issued a draft guidance in August 2026 that would replace its May 1999 guidance on container closure systems for human drugs and biologics, together with the associated May 2002 questions-and-answers document. The draft moves from a dosage-form risk matrix to a product-specific, risk-based and life cycle framework, with extractables and leachables assessment extended to nominally low-risk oral and topical products. It is open for public comment.

Why this mattersPharma packaging suppliers face heavier extractables, leachables and integrity-testing obligations across the product life cycle once the guidance is finalised.

  • The FDA issued the draft guidance on container closure systems for human drugs and biological products in August 2026
  • It is intended to supersede the May 1999 container closure guidance and the associated May 2002 questions-and-answers guidance
  • The draft is currently open for public comment
  • Assessment becomes product-specific, covering formulation, route of administration, system design, manufacturing process and clinical use, rather than resting on dosage-form category
  • Even nominally low-risk oral and topical products require an adequate evaluation of possible leachables
  • Packaging that prepares, delivers or measures a dose, including device constituent parts of combination products, is brought within scope
FDA
Relevant to you?